OR WAIT null SECS
July 16, 2015
The agency has released guidance on bioequivalence studies for asenapine, prasugrel, sitagliptin, and zonisamide.
AMRI expands its API portfolio and European presence through acquisition of Gadea’s Crystal Pharma Group.
July 02, 2015
FDA, Congress, and early adopters look to speed up the use of continuous API manufacturing.
June 15, 2015
BPTF seeks changes in performance goals and fee payment schedule in GDUFA renegotiations.
June 02, 2015
Safer reagents and reaction conditions are making many hazardous transformations possible.
May 13, 2015
Supply chain consortium establishes a working group to address quality problems in India.
May 04, 2015
FDA cites Yunnan Hande Bio-Tech for cGMP violations related to data collection and security.
May 02, 2015
An integrated pilot plant tests heteronucleation and continuous crystallization.
April 16, 2015
Recipharm makes a strategic investment in Synthonics and partners in development of novel compounds.
April 02, 2015
New legislation and changes in policy at FDA are leading to better control of the API supply chain.